Dow Up0.26% Nasdaq Down1.07%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
11.45 Down 0.46(3.86%) Sep 15, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 17,331   26,293   19,643  
Cost of Revenue -   -   -  
Gross Profit 17,331   26,293   19,643  
Operating Expenses
Research Development42,730  51,464  57,249  
Selling General and Administrative5,220  6,826  11,981  
Non Recurring98  1,891   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (30,717) (33,888) (49,587)
Income from Continuing Operations
Total Other Income/Expenses Net5,387  (527)(3,587)
Earnings Before Interest And Taxes(25,330)(34,415)(53,174)
Interest Expense4,778  4,666  3,774  
Income Before Tax(30,108)(39,081)(56,948)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(30,108)(39,081)(56,948)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (30,108) (39,081) (56,948)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (30,108) (39,081) (56,948)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.